Home/Filings/4/0001127602-23-002213
4//SEC Filing

DeLuca Richard R. 4

Accession 0001127602-23-002213

CIK 0000310158other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 4:52 PM ET

Size

5.8 KB

Accession

0001127602-23-002213

Insider Transaction Report

Form 4
Period: 2023-01-23
DeLuca Richard R.
EVP&Pres, Merck Animal Health
Transactions
  • Award

    Common Stock

    2023-01-23$109.88/sh+15,628$1,717,205153,500.379 total
Holdings
  • Common Stock - 401(k) Plan

    (indirect: By 401(k))
    1,198.05
Footnotes (3)
  • [F1]Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/20. Performance shares were paid out at 110 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2022.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.
  • [F3]Includes shares acquired and dividends earned through January 9, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001421339

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:52 PM ET
Size
5.8 KB